nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Infection—Methylprednisolone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Methylphenidate—Haematuria—Methotrexate—psoriatic arthritis	0.000852	0.000852	CcSEcCtD
Methylphenidate—Shock—Triamcinolone—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Methylphenidate—Insomnia—Prednisolone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Methylphenidate—Alopecia—Prednisone—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Methylphenidate—Shock—Methylprednisolone—psoriatic arthritis	0.000848	0.000848	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000846	0.000846	CcSEcCtD
Methylphenidate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000845	0.000845	CcSEcCtD
Methylphenidate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000844	0.000844	CcSEcCtD
Methylphenidate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000844	0.000844	CcSEcCtD
Methylphenidate—Epistaxis—Methotrexate—psoriatic arthritis	0.000843	0.000843	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisolone—psoriatic arthritis	0.000843	0.000843	CcSEcCtD
Methylphenidate—Tachycardia—Triamcinolone—psoriatic arthritis	0.000843	0.000843	CcSEcCtD
Methylphenidate—Mental disorder—Prednisone—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Methylphenidate—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Methylphenidate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000837	0.000837	CcSEcCtD
Methylphenidate—Erythema—Prednisone—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Methylphenidate—Malnutrition—Prednisone—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Methylphenidate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000835	0.000835	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000833	0.000833	CcSEcCtD
Methylphenidate—Convulsion—Dexamethasone—psoriatic arthritis	0.000832	0.000832	CcSEcCtD
Methylphenidate—Convulsion—Betamethasone—psoriatic arthritis	0.000832	0.000832	CcSEcCtD
Methylphenidate—Hypertension—Betamethasone—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Methylphenidate—Hypertension—Dexamethasone—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Methylphenidate—Myalgia—Betamethasone—psoriatic arthritis	0.000817	0.000817	CcSEcCtD
Methylphenidate—Myalgia—Dexamethasone—psoriatic arthritis	0.000817	0.000817	CcSEcCtD
Methylphenidate—Anxiety—Betamethasone—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Methylphenidate—Anxiety—Dexamethasone—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Methylphenidate—Discomfort—Betamethasone—psoriatic arthritis	0.000808	0.000808	CcSEcCtD
Methylphenidate—Discomfort—Dexamethasone—psoriatic arthritis	0.000808	0.000808	CcSEcCtD
Methylphenidate—Haemoglobin—Methotrexate—psoriatic arthritis	0.000807	0.000807	CcSEcCtD
Methylphenidate—Pain—Prednisolone—psoriatic arthritis	0.000803	0.000803	CcSEcCtD
Methylphenidate—Haemorrhage—Methotrexate—psoriatic arthritis	0.000803	0.000803	CcSEcCtD
Methylphenidate—Pharyngitis—Methotrexate—psoriatic arthritis	0.000797	0.000797	CcSEcCtD
Methylphenidate—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000793	0.000793	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—psoriatic arthritis	0.000788	0.000788	CcSEcCtD
Methylphenidate—Urethral disorder—Methotrexate—psoriatic arthritis	0.000787	0.000787	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000787	0.000787	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Methylphenidate—Oedema—Dexamethasone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Methylphenidate—Oedema—Betamethasone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Methylphenidate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Methylphenidate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Methylphenidate—Insomnia—Triamcinolone—psoriatic arthritis	0.000781	0.000781	CcSEcCtD
Methylphenidate—Insomnia—Methylprednisolone—psoriatic arthritis	0.000779	0.000779	CcSEcCtD
Methylphenidate—Infection—Dexamethasone—psoriatic arthritis	0.000778	0.000778	CcSEcCtD
Methylphenidate—Infection—Betamethasone—psoriatic arthritis	0.000778	0.000778	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000776	0.000776	CcSEcCtD
Methylphenidate—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000775	0.000775	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000774	0.000774	CcSEcCtD
Methylphenidate—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000774	0.000774	CcSEcCtD
Methylphenidate—Visual impairment—Methotrexate—psoriatic arthritis	0.000773	0.000773	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—psoriatic arthritis	0.000773	0.000773	CcSEcCtD
Methylphenidate—Shock—Dexamethasone—psoriatic arthritis	0.000771	0.000771	CcSEcCtD
Methylphenidate—Shock—Betamethasone—psoriatic arthritis	0.000771	0.000771	CcSEcCtD
Methylphenidate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00077	0.00077	CcSEcCtD
Methylphenidate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000768	0.000768	CcSEcCtD
Methylphenidate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000768	0.000768	CcSEcCtD
Methylphenidate—Agitation—Prednisone—psoriatic arthritis	0.000768	0.000768	CcSEcCtD
Methylphenidate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000767	0.000767	CcSEcCtD
Methylphenidate—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000767	0.000767	CcSEcCtD
Methylphenidate—Tachycardia—Dexamethasone—psoriatic arthritis	0.000765	0.000765	CcSEcCtD
Methylphenidate—Tachycardia—Betamethasone—psoriatic arthritis	0.000765	0.000765	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—psoriatic arthritis	0.000764	0.000764	CcSEcCtD
Methylphenidate—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00076	0.00076	CcSEcCtD
Methylphenidate—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000759	0.000759	CcSEcCtD
Methylphenidate—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000758	0.000758	CcSEcCtD
Methylphenidate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000757	0.000757	CcSEcCtD
Methylphenidate—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000757	0.000757	CcSEcCtD
Methylphenidate—Malaise—Prednisone—psoriatic arthritis	0.000754	0.000754	CcSEcCtD
Methylphenidate—Vertigo—Prednisone—psoriatic arthritis	0.000751	0.000751	CcSEcCtD
Methylphenidate—Eye disorder—Methotrexate—psoriatic arthritis	0.00075	0.00075	CcSEcCtD
Methylphenidate—Syncope—Prednisone—psoriatic arthritis	0.00075	0.00075	CcSEcCtD
Methylphenidate—Anorexia—Dexamethasone—psoriatic arthritis	0.000747	0.000747	CcSEcCtD
Methylphenidate—Anorexia—Betamethasone—psoriatic arthritis	0.000747	0.000747	CcSEcCtD
Methylphenidate—Urticaria—Prednisolone—psoriatic arthritis	0.000746	0.000746	CcSEcCtD
Methylphenidate—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Methylphenidate—Fatigue—Triamcinolone—psoriatic arthritis	0.000744	0.000744	CcSEcCtD
Methylphenidate—Fatigue—Methylprednisolone—psoriatic arthritis	0.000743	0.000743	CcSEcCtD
Methylphenidate—Pain—Triamcinolone—psoriatic arthritis	0.000738	0.000738	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisone—psoriatic arthritis	0.000735	0.000735	CcSEcCtD
Methylphenidate—Angiopathy—Methotrexate—psoriatic arthritis	0.000728	0.000728	CcSEcCtD
Methylphenidate—Immune system disorder—Methotrexate—psoriatic arthritis	0.000725	0.000725	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—psoriatic arthritis	0.000724	0.000724	CcSEcCtD
Methylphenidate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000723	0.000723	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—psoriatic arthritis	0.000722	0.000722	CcSEcCtD
Methylphenidate—Chills—Methotrexate—psoriatic arthritis	0.00072	0.00072	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000714	0.000714	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000714	0.000714	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—psoriatic arthritis	0.000712	0.000712	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—psoriatic arthritis	0.000712	0.000712	CcSEcCtD
Methylphenidate—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000712	0.000712	CcSEcCtD
Methylphenidate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00071	0.00071	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Methylphenidate—Alopecia—Methotrexate—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Methylphenidate—Insomnia—Dexamethasone—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Methylphenidate—Insomnia—Betamethasone—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000707	0.000707	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000705	0.000705	CcSEcCtD
Methylphenidate—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000704	0.000704	CcSEcCtD
Methylphenidate—Paraesthesia—Betamethasone—psoriatic arthritis	0.000704	0.000704	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—psoriatic arthritis	0.000703	0.000703	CcSEcCtD
Methylphenidate—Mental disorder—Methotrexate—psoriatic arthritis	0.000703	0.000703	CcSEcCtD
Methylphenidate—Erythema—Methotrexate—psoriatic arthritis	0.000699	0.000699	CcSEcCtD
Methylphenidate—Malnutrition—Methotrexate—psoriatic arthritis	0.000699	0.000699	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000692	0.000692	CcSEcCtD
Methylphenidate—Dyspepsia—Betamethasone—psoriatic arthritis	0.00069	0.00069	CcSEcCtD
Methylphenidate—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00069	0.00069	CcSEcCtD
Methylphenidate—Urticaria—Triamcinolone—psoriatic arthritis	0.000686	0.000686	CcSEcCtD
Methylphenidate—Urticaria—Methylprednisolone—psoriatic arthritis	0.000684	0.000684	CcSEcCtD
Methylphenidate—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000683	0.000683	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000682	0.000682	CcSEcCtD
Methylphenidate—Oedema—Prednisone—psoriatic arthritis	0.000682	0.000682	CcSEcCtD
Methylphenidate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000681	0.000681	CcSEcCtD
Methylphenidate—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000681	0.000681	CcSEcCtD
Methylphenidate—Decreased appetite—Betamethasone—psoriatic arthritis	0.000681	0.000681	CcSEcCtD
Methylphenidate—Infection—Prednisone—psoriatic arthritis	0.000678	0.000678	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Methylphenidate—Back pain—Methotrexate—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Methylphenidate—Fatigue—Dexamethasone—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Methylphenidate—Fatigue—Betamethasone—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Methylphenidate—Shock—Prednisone—psoriatic arthritis	0.000671	0.000671	CcSEcCtD
Methylphenidate—Pain—Dexamethasone—psoriatic arthritis	0.00067	0.00067	CcSEcCtD
Methylphenidate—Pain—Betamethasone—psoriatic arthritis	0.00067	0.00067	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—psoriatic arthritis	0.000669	0.000669	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—psoriatic arthritis	0.000666	0.000666	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—psoriatic arthritis	0.000663	0.000663	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00066	0.00066	CcSEcCtD
Methylphenidate—Vision blurred—Methotrexate—psoriatic arthritis	0.000658	0.000658	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—psoriatic arthritis	0.00065	0.00065	CcSEcCtD
Methylphenidate—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000648	0.000648	CcSEcCtD
Methylphenidate—Anaemia—Methotrexate—psoriatic arthritis	0.000646	0.000646	CcSEcCtD
Methylphenidate—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000646	0.000646	CcSEcCtD
Methylphenidate—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000646	0.000646	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000641	0.000641	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000641	0.000641	CcSEcCtD
Methylphenidate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000636	0.000636	CcSEcCtD
Methylphenidate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000635	0.000635	CcSEcCtD
Methylphenidate—Malaise—Methotrexate—psoriatic arthritis	0.00063	0.00063	CcSEcCtD
Methylphenidate—Vertigo—Methotrexate—psoriatic arthritis	0.000628	0.000628	CcSEcCtD
Methylphenidate—Leukopenia—Methotrexate—psoriatic arthritis	0.000625	0.000625	CcSEcCtD
Methylphenidate—Urticaria—Dexamethasone—psoriatic arthritis	0.000622	0.000622	CcSEcCtD
Methylphenidate—Urticaria—Betamethasone—psoriatic arthritis	0.000622	0.000622	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000622	0.000622	CcSEcCtD
Methylphenidate—Dizziness—Prednisolone—psoriatic arthritis	0.000621	0.000621	CcSEcCtD
Methylphenidate—Asthenia—Triamcinolone—psoriatic arthritis	0.00062	0.00062	CcSEcCtD
Methylphenidate—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000619	0.000619	CcSEcCtD
Methylphenidate—Abdominal pain—Betamethasone—psoriatic arthritis	0.000619	0.000619	CcSEcCtD
Methylphenidate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000619	0.000619	CcSEcCtD
Methylphenidate—Body temperature increased—Betamethasone—psoriatic arthritis	0.000619	0.000619	CcSEcCtD
Methylphenidate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000618	0.000618	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—psoriatic arthritis	0.000617	0.000617	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—psoriatic arthritis	0.000613	0.000613	CcSEcCtD
Methylphenidate—Pruritus—Triamcinolone—psoriatic arthritis	0.000611	0.000611	CcSEcCtD
Methylphenidate—Cough—Methotrexate—psoriatic arthritis	0.00061	0.00061	CcSEcCtD
Methylphenidate—Pruritus—Methylprednisolone—psoriatic arthritis	0.00061	0.00061	CcSEcCtD
Methylphenidate—Convulsion—Methotrexate—psoriatic arthritis	0.000605	0.000605	CcSEcCtD
Methylphenidate—Dyspepsia—Prednisone—psoriatic arthritis	0.000601	0.000601	CcSEcCtD
Methylphenidate—Arthralgia—Methotrexate—psoriatic arthritis	0.000595	0.000595	CcSEcCtD
Methylphenidate—Chest pain—Methotrexate—psoriatic arthritis	0.000595	0.000595	CcSEcCtD
Methylphenidate—Myalgia—Methotrexate—psoriatic arthritis	0.000595	0.000595	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—psoriatic arthritis	0.000593	0.000593	CcSEcCtD
Methylphenidate—Rash—Prednisolone—psoriatic arthritis	0.000592	0.000592	CcSEcCtD
Methylphenidate—Dermatitis—Prednisolone—psoriatic arthritis	0.000591	0.000591	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000591	0.000591	CcSEcCtD
Methylphenidate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00059	0.00059	CcSEcCtD
Methylphenidate—Fatigue—Prednisone—psoriatic arthritis	0.000588	0.000588	CcSEcCtD
Methylphenidate—Headache—Prednisolone—psoriatic arthritis	0.000588	0.000588	CcSEcCtD
Methylphenidate—Discomfort—Methotrexate—psoriatic arthritis	0.000588	0.000588	CcSEcCtD
Methylphenidate—Constipation—Prednisone—psoriatic arthritis	0.000583	0.000583	CcSEcCtD
Methylphenidate—Confusional state—Methotrexate—psoriatic arthritis	0.000575	0.000575	CcSEcCtD
Methylphenidate—Dizziness—Triamcinolone—psoriatic arthritis	0.000571	0.000571	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00057	0.00057	CcSEcCtD
Methylphenidate—Dizziness—Methylprednisolone—psoriatic arthritis	0.00057	0.00057	CcSEcCtD
Methylphenidate—Infection—Methotrexate—psoriatic arthritis	0.000567	0.000567	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—psoriatic arthritis	0.000562	0.000562	CcSEcCtD
Methylphenidate—Asthenia—Betamethasone—psoriatic arthritis	0.000562	0.000562	CcSEcCtD
Methylphenidate—Asthenia—Dexamethasone—psoriatic arthritis	0.000562	0.000562	CcSEcCtD
Methylphenidate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000559	0.000559	CcSEcCtD
Methylphenidate—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000558	0.000558	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000558	0.000558	CcSEcCtD
Methylphenidate—Nausea—Prednisolone—psoriatic arthritis	0.000558	0.000558	CcSEcCtD
Methylphenidate—Pruritus—Dexamethasone—psoriatic arthritis	0.000554	0.000554	CcSEcCtD
Methylphenidate—Pruritus—Betamethasone—psoriatic arthritis	0.000554	0.000554	CcSEcCtD
Methylphenidate—Skin disorder—Methotrexate—psoriatic arthritis	0.000554	0.000554	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000551	0.000551	CcSEcCtD
Methylphenidate—Vomiting—Triamcinolone—psoriatic arthritis	0.000549	0.000549	CcSEcCtD
Methylphenidate—Vomiting—Methylprednisolone—psoriatic arthritis	0.000548	0.000548	CcSEcCtD
Methylphenidate—Rash—Triamcinolone—psoriatic arthritis	0.000544	0.000544	CcSEcCtD
Methylphenidate—Dermatitis—Triamcinolone—psoriatic arthritis	0.000544	0.000544	CcSEcCtD
Methylphenidate—Anorexia—Methotrexate—psoriatic arthritis	0.000544	0.000544	CcSEcCtD
Methylphenidate—Rash—Methylprednisolone—psoriatic arthritis	0.000543	0.000543	CcSEcCtD
Methylphenidate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000543	0.000543	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—psoriatic arthritis	0.000542	0.000542	CcSEcCtD
Methylphenidate—Headache—Triamcinolone—psoriatic arthritis	0.000541	0.000541	CcSEcCtD
Methylphenidate—Headache—Methylprednisolone—psoriatic arthritis	0.00054	0.00054	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—psoriatic arthritis	0.000539	0.000539	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—psoriatic arthritis	0.000539	0.000539	CcSEcCtD
Methylphenidate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000536	0.000536	CcSEcCtD
Methylphenidate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000536	0.000536	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00052	0.00052	CcSEcCtD
Methylphenidate—Dizziness—Dexamethasone—psoriatic arthritis	0.000518	0.000518	CcSEcCtD
Methylphenidate—Dizziness—Betamethasone—psoriatic arthritis	0.000518	0.000518	CcSEcCtD
Methylphenidate—Insomnia—Methotrexate—psoriatic arthritis	0.000516	0.000516	CcSEcCtD
Methylphenidate—Nausea—Triamcinolone—psoriatic arthritis	0.000513	0.000513	CcSEcCtD
Methylphenidate—Paraesthesia—Methotrexate—psoriatic arthritis	0.000512	0.000512	CcSEcCtD
Methylphenidate—Nausea—Methylprednisolone—psoriatic arthritis	0.000512	0.000512	CcSEcCtD
Methylphenidate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000508	0.000508	CcSEcCtD
Methylphenidate—Somnolence—Methotrexate—psoriatic arthritis	0.000507	0.000507	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—psoriatic arthritis	0.000503	0.000503	CcSEcCtD
Methylphenidate—Dyspepsia—Methotrexate—psoriatic arthritis	0.000502	0.000502	CcSEcCtD
Methylphenidate—Vomiting—Dexamethasone—psoriatic arthritis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Vomiting—Betamethasone—psoriatic arthritis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Decreased appetite—Methotrexate—psoriatic arthritis	0.000496	0.000496	CcSEcCtD
Methylphenidate—Rash—Dexamethasone—psoriatic arthritis	0.000494	0.000494	CcSEcCtD
Methylphenidate—Rash—Betamethasone—psoriatic arthritis	0.000494	0.000494	CcSEcCtD
Methylphenidate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000494	0.000494	CcSEcCtD
Methylphenidate—Dermatitis—Betamethasone—psoriatic arthritis	0.000494	0.000494	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000492	0.000492	CcSEcCtD
Methylphenidate—Fatigue—Methotrexate—psoriatic arthritis	0.000492	0.000492	CcSEcCtD
Methylphenidate—Headache—Betamethasone—psoriatic arthritis	0.000491	0.000491	CcSEcCtD
Methylphenidate—Headache—Dexamethasone—psoriatic arthritis	0.000491	0.000491	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—psoriatic arthritis	0.00049	0.00049	CcSEcCtD
Methylphenidate—Pain—Methotrexate—psoriatic arthritis	0.000488	0.000488	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—psoriatic arthritis	0.000483	0.000483	CcSEcCtD
Methylphenidate—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00047	0.00047	CcSEcCtD
Methylphenidate—Diarrhoea—Prednisone—psoriatic arthritis	0.000467	0.000467	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000466	0.000466	CcSEcCtD
Methylphenidate—Nausea—Betamethasone—psoriatic arthritis	0.000465	0.000465	CcSEcCtD
Methylphenidate—Nausea—Dexamethasone—psoriatic arthritis	0.000465	0.000465	CcSEcCtD
Methylphenidate—Urticaria—Methotrexate—psoriatic arthritis	0.000453	0.000453	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—psoriatic arthritis	0.000451	0.000451	CcSEcCtD
Methylphenidate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000451	0.000451	CcSEcCtD
Methylphenidate—Body temperature increased—Methotrexate—psoriatic arthritis	0.000451	0.000451	CcSEcCtD
Methylphenidate—Vomiting—Prednisone—psoriatic arthritis	0.000434	0.000434	CcSEcCtD
Methylphenidate—Rash—Prednisone—psoriatic arthritis	0.00043	0.00043	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—psoriatic arthritis	0.00043	0.00043	CcSEcCtD
Methylphenidate—Headache—Prednisone—psoriatic arthritis	0.000427	0.000427	CcSEcCtD
Methylphenidate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00042	0.00042	CcSEcCtD
Methylphenidate—Asthenia—Methotrexate—psoriatic arthritis	0.000409	0.000409	CcSEcCtD
Methylphenidate—Nausea—Prednisone—psoriatic arthritis	0.000405	0.000405	CcSEcCtD
Methylphenidate—Pruritus—Methotrexate—psoriatic arthritis	0.000403	0.000403	CcSEcCtD
Methylphenidate—Diarrhoea—Methotrexate—psoriatic arthritis	0.00039	0.00039	CcSEcCtD
Methylphenidate—Dizziness—Methotrexate—psoriatic arthritis	0.000377	0.000377	CcSEcCtD
Methylphenidate—Vomiting—Methotrexate—psoriatic arthritis	0.000363	0.000363	CcSEcCtD
Methylphenidate—Rash—Methotrexate—psoriatic arthritis	0.00036	0.00036	CcSEcCtD
Methylphenidate—Dermatitis—Methotrexate—psoriatic arthritis	0.000359	0.000359	CcSEcCtD
Methylphenidate—Headache—Methotrexate—psoriatic arthritis	0.000357	0.000357	CcSEcCtD
Methylphenidate—Nausea—Methotrexate—psoriatic arthritis	0.000339	0.000339	CcSEcCtD
